Prediction of Hearing Preservation in Vestibular Schwannoma Surgery According to Tumor Size and Anatomic Extension.

Erlangen vestibula schwannoma grading Koos vestibular schwannoma grading grading systems hearing preservation vestibular schwannoma surgery

Journal

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176

Informations de publication

Date de publication:
03 2022
Historique:
pubmed: 26 5 2021
medline: 21 4 2022
entrez: 25 5 2021
Statut: ppublish

Résumé

Vestibular schwannoma (VS) surgery is feasible for various tumor sizes that are inappropriate for wait and scan or radiosurgery. The predictive value of 2 grading systems was investigated for postoperative hearing preservation (HP) in a large series. Retrospective analysis. Neurosurgical patient database of the University of Erlangen was queried between 2014 and 2017. Retrospective single-center analysis on 138 VSs operated on via a retrosigmoidal approach. The mean tumor size was 20.4 mm (SD, 7.6 mm) with fundal infiltration in 67.4%. The overall resection rate was 93.5%. Tumors were classified preoperatively by the 3-tier Erlangen grading system depending on size or the anatomically based 4-tier Koos grading system. Preoperative hearing preservation was found in 70.3% of patients and was significantly correlated to tumor size ( Surgery on small VSs can achieve excellent hearing preservation. Different grading has a significant influence on and correlates with postoperative hearing preservation. Tumor size seems more important than anatomic relationship.

Identifiants

pubmed: 34030502
doi: 10.1177/01945998211012674
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

530-536

Auteurs

Yavor Bozhkov (Y)

Neurosurgical Clinic, University Hospital Erlangen, Erlangen, Germany.

Julia Shawarba (J)

Neurosurgical Clinic, University Hospital Erlangen, Erlangen, Germany.

Julian Feulner (J)

Neurosurgical Clinic, University Hospital Erlangen, Erlangen, Germany.

Fabian Winter (F)

Neurosurgical Clinic, Medical University Vienna, Vienna, Austria.

Stefan Rampp (S)

Neurosurgical Clinic, University Hospital Erlangen, Erlangen, Germany.

Ullrich Hoppe (U)

ENT Clinic, University Hospital Erlangen, Erlangen, Germany.

Arnd Doerfler (A)

Department of Neuroradiolgy, University Hospital Erlangen, Erlangen, Germany.

Heinrich Iro (H)

ENT Clinic, University Hospital Erlangen, Erlangen, Germany.

Michael Buchfelder (M)

Neurosurgical Clinic, University Hospital Erlangen, Erlangen, Germany.

Karl Roessler (K)

Neurosurgical Clinic, University Hospital Erlangen, Erlangen, Germany.
Neurosurgical Clinic, Medical University Vienna, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH